Q3 2023 13F Holders as of 9/30/2023
-
Type / Class
-
Equity / Ordinary Shares, par value 0.00001 NIS per share
-
Shares outstanding
-
240M
-
Number of holders
-
93
-
Total 13F shares, excl. options
-
53.3M
-
Shares change
-
+14.4M
-
Total reported value, excl. options
-
$403M
-
Value change
-
+$106M
-
Put/Call ratio
-
0.24
-
Number of buys
-
68
-
Number of sells
-
-20
-
Price
-
$7.65
Significant Holders of Cellebrite DI Ltd. - Ordinary Shares, par value 0.00001 NIS per share (CLBT) as of Q3 2023
104 filings reported holding CLBT - Cellebrite DI Ltd. - Ordinary Shares, par value 0.00001 NIS per share as of Q3 2023.
Cellebrite DI Ltd. - Ordinary Shares, par value 0.00001 NIS per share (CLBT) has 93 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 53.3M shares
of 240M outstanding shares and own 22.18% of the company stock.
Largest 10 shareholders include True Wind Capital Management, L.P. (13.4M shares), Clal Insurance Enterprises Holdings Ltd (6.57M shares), Phoenix Holdings Ltd. (6.02M shares), CROSSLINK CAPITAL INC (3.2M shares), MAKENA CAPITAL MANAGEMENT LLC (3.15M shares), MORGAN STANLEY (2.33M shares), LIGHT STREET CAPITAL MANAGEMENT, LLC (2.06M shares), Isomer Partners LP (1.65M shares), ACADIAN ASSET MANAGEMENT LLC (1.65M shares), and MILLENNIUM MANAGEMENT LLC (1.08M shares).
This table shows the top 93 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.